AI ScreeningAI ChatPricing
  1. US-listed companies
  2. Akari Therapeutics Plc
  3. Raw

Akari Therapeutics Plc【AKTX】

Market cap
$16.5B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Cash86693428561491343
Restricted cash-----------60,000
Prepaid expenses--------2465,24400
Other current assets--------90,30199,54300
Total current assets867046297715121443
Goodwill-----------8
Other intangible assets-----------39
Patent acquisition costs, net--52,48339,36539,12432,97830,16327,15022,92916,8800-
Total assets8670462987151214451
Accounts payable--4222132946,658212
Accrued expenses--408,222251423323
Convertible Debt-----------1
Convertible Debt Related Party-----------0
Notes payable-----------1
Notes payable, related party-----------2
Warrant liabilities---------811
Other current liabilities---------94,11800
Total current liabilities112112125-----20
Other non-current liabilities-0---------0
Deferred tax liability-----------8
Total liabilities--211212595612528
Common Stock, Value, Issued111818232432384,733475,973744,49215
Additional paid-in capital26348791105107110140153167175213
Capital redemption reserve-------5252525252
Accumulated other comprehensive loss--156,480-280,097-236,246-352,426-348,860-648,065-540,967-770,839-1-1
Accumulated deficit-21-30-56,796,613-74,937,610-110,336,867-126,803,647-143,909,438-182,280,811-199,705,048-217,453,110-227-247
Total shareholders' equity (deficit)654934173-1,772,458962-022
Total liabilities and shareholders' equity (deficit)8670462987151214451